©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Sep 5, 2025; 16(3): 107167
Published online Sep 5, 2025. doi: 10.4292/wjgpt.v16.i3.107167
Published online Sep 5, 2025. doi: 10.4292/wjgpt.v16.i3.107167
Table 2 Technical success, complications and outcome of patients
| Outcome | ERCP (n = 12) | PTBD (n = 21) | P value |
| Technical success | 12 (100.0) | 21 (100.0) | |
| Therapeutic success | 11 (91.7) | 12 (57.1) | 0.03 |
| Complications | |||
| Total complications | 2 (16.7) | 12 (57.1) | 0.02 |
| Hospital acquired infections | 2 (16.7) | 11 (52.4) | 0.04 |
| Pulmonary complications | 1 (8.3) | 6 (28.6) | 0.17 |
| Dislodgement | 0 (0.0) | 3 (14.3) | 0.17 |
| Arrhythmias | 0 (0.0) | 1 (4.7) | 0.44 |
| Bleeding | 0 (0.0) | 2 (4.8) | 0.44 |
| Mortality | 0 (0.0) | 5 (23.8) | 0.06 |
| Readmission | 1 (8.3) | 4 (19.1) | 0.40 |
- Citation: Karim MM, Moatter S, Amin M, Parkash O. Comparison of endoscopic retrograde cholangiopancreatography drainage vs percutaneous transhepatic biliary drainage in severe cholangitis: A study from low-middle income country. World J Gastrointest Pharmacol Ther 2025; 16(3): 107167
- URL: https://www.wjgnet.com/2150-5349/full/v16/i3/107167.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v16.i3.107167